C07D 495/12
In which the condensed system contains three hetero rings
Official title: in which the condensed system contains three hetero rings
C07D495/12 (In which the condensed system contains three hetero rings) appears on 1,200 US grants and 1,380 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,200
- Published applications
- 1,380
- Assignees
- 625
- Inventors
- 4,169
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 2 | 0 |
| 1978 | 6 | 0 |
| 1979 | 6 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 25 | 0 |
| 1983 | 17 | 0 |
| 1984 | 6 | 0 |
| 1985 | 6 | 0 |
| 1986 | 5 | 0 |
| 1987 | 12 | 0 |
| 1988 | 13 | 0 |
| 1989 | 16 | 0 |
| 1990 | 13 | 0 |
| 1991 | 12 | 0 |
| 1992 | 17 | 0 |
| 1993 | 8 | 0 |
| 1994 | 12 | 0 |
| 1995 | 24 | 0 |
| 1996 | 8 | 0 |
| 1997 | 24 | 0 |
| 1998 | 16 | 0 |
| 1999 | 10 | 0 |
| 2000 | 11 | 0 |
| 2001 | 13 | 1 |
| 2002 | 12 | 19 |
| 2003 | 17 | 25 |
| 2004 | 15 | 18 |
| 2005 | 16 | 23 |
| 2006 | 11 | 25 |
| 2007 | 14 | 34 |
| 2008 | 13 | 29 |
| 2009 | 14 | 34 |
| 2010 | 25 | 41 |
| 2011 | 29 | 50 |
| 2012 | 25 | 52 |
| 2013 | 39 | 48 |
| 2014 | 42 | 65 |
| 2015 | 54 | 71 |
| 2016 | 57 | 63 |
| 2017 | 62 | 59 |
| 2018 | 45 | 78 |
| 2019 | 57 | 83 |
| 2020 | 54 | 83 |
| 2021 | 59 | 86 |
| 2022 | 52 | 79 |
| 2023 | 51 | 89 |
| 2024 | 59 | 78 |
| 2025 | 47 | 85 |
| 2026 | 33 | 62 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cyclic compounds and methods of using same25 Aug 2026US 12,715,876 B2Schrödinger, Inc.
- Protein degraders and uses thereof25 Aug 2026US 12,715,877 B2Kymera Therapeutics, Inc.
- p53 modulators and uses thereof28 Jul 2026US 12,692,273 B2The Regents of the University of California
- Heterocyclic pericondensed CDC7 kinase inhibitors for the treatment of cancer21 Jul 2026US 12,686,688 B2Schrödinger, Inc.
- Indolo[3.2.1-jk]carbazole-6-carbonitrile derivatives as blue fluorescent emitters for use in OLEDS21 Jul 2026US 12,690,385 B2
- Heterobifunctional compounds and methods of treating disease8 Oct 2026US 2026/0308171 A1Halda Therapeutics OpCo, Inc.
- Compound for organic photoelectric element, organic photoelectric element, image sensor and electronic device comprising the same8 Oct 2026US 2026/0314261 A1Duk San Neolux Co., Ltd.
- Compounds as sumo activating enzyme inhibitors1 Oct 2026US 2026/0297109 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Substituted thiophene fused derivatives, compositions comprising the same and their use as pharmaceuticals24 Sep 2026US 2026/0285829 A1Neurasic Therapeutics Inc.
- Inhibitors of parg24 Sep 2026US 2026/0285875 A1858 Therapeutics, Inc.
Most cited
By later US patents
- Tricyclic fused thiophene derivatives as JAK inhibitors102US 9,181,271 B2Incyte Corporation · 2015
- Thienotriazolodiazepine compound and pharmaceutical use thereof84US 5,721,231 AYoshitomi Pharmaceutical Industries, Ltd. · 1998
- Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings84US 6,716,979 B2Molecular Probes, Inc. · 2004
- Opioid agonist compounds78US 5,225,417 AG. D. Searle & Co. · 1993
- Fused heteroaryl derivatives77US 6,608,053 B2Imperial Cancer Research Technology, Ltd. · 2003